Zobrazeno 1 - 10
of 95
pro vyhledávání: '"Victor S. Lobanov"'
Publikováno v:
Slas Technology
Covance Drug Development produces more than 55 million test results via its central laboratory services, requiring the delivery of more than 10 million reports annually to investigators at 35,000 sites in 89 countries. Historically, most of these dat
Publikováno v:
ICHI
Named entity recognition (NER) is fundamental to the computerization of clinical trial eligibility criteria text. In this study, we fine-tuned pretrained contextual language models to support the NER task on clinical trial eligibility criteria. We sy
Autor:
Kristin Stallcup, Victor S. Lobanov, Michael A Farnum, Shih Chuan Shen, Joseph Ciervo, Abraham Thomas, Dimitris K. Agrafiotis
Publikováno v:
JAMIA Open
Objective We present a new system to track, manage, and report on all risks and issues encountered during a clinical trial. Materials and Methods Our solution utilizes JIRA, a popular issue and project tracking tool for software development, augmente
Publikováno v:
ClinicalNLP@EMNLP
In drug development, protocols define how clinical trials are conducted, and are therefore of paramount importance. They contain key patient-, investigator-, medication-, and study-related information, often elaborated in different sections in the pr
Autor:
Jeremy D Scheff, Dimitris K. Agrafiotis, Eric Yang, Victor S. Lobanov, Shih C Shen, Michael A Farnum, James Sefton
Publikováno v:
Database: The Journal of Biological Databases and Curation
Clinical trial data are typically collected through multiple systems developed by different vendors using different technologies and data standards. That data need to be integrated, standardized and transformed for a variety of monitoring and reporti
Autor:
Fang Du, Michael A Farnum, Lalit Mohanty, Dimitris K. Agrafiotis, Mathangi Ashok, Victor S. Lobanov, Paul Konstant, Daniel Kowalski, Joseph Ciervo
Publikováno v:
Database: The Journal of Biological Databases and Curation
Assembly of complete and error-free clinical trial data sets for statistical analysis and regulatory submission requires extensive effort and communication among investigational sites, central laboratories, pharmaceutical sponsors, contract research
Autor:
Victor S. Lobanov, Paul Konstant, Michael A Farnum, Joseph Ciervo, Dimitris K. Agrafiotis, Lalit Mohanty, Mathangi Ashok
Publikováno v:
Database: The Journal of Biological Databases and Curation
Timely, consistent and integrated access to clinical trial data remains one of the pharmaceutical industry’s most pressing needs. As part of a comprehensive clinical data repository, we have developed a data warehouse that can integrate operational
Autor:
Adam Baumgart, Michael A Farnum, Aaron J. Mackey, Michael Walega, Victor S. Lobanov, Dimitris K. Agrafiotis, Eric Yang, Joseph Ciervo
Publikováno v:
Clinical therapeutics. 40(7)
Purpose Clinical trial monitoring is an essential component of drug development aimed at safeguarding subject safety, data quality, and protocol compliance by focusing sponsor oversight on the most important aspects of study conduct. In recent years,
Publikováno v:
The Journal of Pain. 14(4):405-411
ClinicalTrials.gov is a registry and results database of federally and privately supported clinical trials conducted worldwide. We sought to answer: what are the characteristics of pain trials; how frequently are these trials stopped and why; what is
Autor:
Vaibhav A. Narayan, Eric Yang, Mahesh N. Samtani, Victor S. Lobanov, Michael Farnum, Yingqi Shi, Allitia DiBernardo, Tim Schultz, Nandini Raghavan, Gerald Novak
Publikováno v:
British Journal of Clinical Pharmacology. 75:146-161
WHAT IS ALREADY KNOWN ABOUT THIS SUBJECT • Amnestic mild cognitive impairment MCI) represents the prodromal stage of Alzheimer's dementia and this disease progresses in a non-linear fashion. • Disease progression depends on a variety of demograph